
- Applied Clinical Trials-11-01-2006
- Volume 0
- Issue 0
eShowcase: Clintrace 4.1
Release takes adverse event reporting to a new level, complies with FDA's new rules
Release takes adverse event reporting to a new level, complies with FDA's new rules
Phase Forward Inc.(Waltham, MA) released version 4.1 of its adverse event reporting and regulatory compliance solution software, Clintrace. A result of Clintrace's integration with Cognos Inc.'s ReportNet software, Clintrace now has additional adverse event and operational information reporting capabilities, as well as enhanced data analysis capabilities. Clintrace 4.1 also features compliance with FDA's MedWatch 3500A form, the new online mechanism for mandatory reporting of serious adverse events, potential and actual medical product errors, and product quality problems involving FDA-regulated drugs, devices, biologics, and dietary supplements.
Clintrace 4.1
The integration with Cognos ReportNet, which offers a single authoring environment for creating reports to improve decision making, will let Clintrace users build their own reports without IT involvement. This, the company says, will afford added flexibility and cost- and time-saving opportunities.
Phase Forward Inc., (888) 703-1122,
Articles in this issue
almost 19 years ago
Building Your Clinical IT Teamalmost 19 years ago
Tough Trials Ahead for Europe's Drug Industryalmost 19 years ago
Experts Urge Major Overhaul at FDAalmost 19 years ago
Recruitment & Consent in Indiaalmost 19 years ago
eShowcase: iPlan Flowalmost 19 years ago
Pharmacogenomics Enters the Japanese Marketalmost 19 years ago
Meet the EAB: Somesh Nigamalmost 19 years ago
Merging eHR & EDC Conferencealmost 19 years ago
Deploying Mobile Devices in Clinical Trials: Part Twoalmost 19 years ago
eShowcase: PharmaReady V3.0Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.